Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - CUMBERLAND PHARMACEUTICALS INC | c16812e10vq.htm |
| EX-31.1 - EXHIBIT 31.1 - CUMBERLAND PHARMACEUTICALS INC | c16812exv31w1.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE AND
PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2011 of
Cumberland Pharmaceuticals Inc. (the “Company”), as filed with the Securities and Exchange
Commission on the date hereof (the “Report”), I, A.J. Kazimi, Chief Executive and Principal
Financial Officer of the Company, certify, pursuant to Section 906 of the Sarbanes-Oxley Act of
2002 (18 U.S.C. section 1350), that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company. |
| /s/ A. J. Kazimi
|
||||
| Chief Executive and Principal Financial Officer |
||||
| May 9, 2011 |